ClinicalTrials.gg
Sign In

Intestinal Neoplasms clinical trials

The registry lists 110 studies for Intestinal Neoplasms across more than 10 countries. 25 are recruiting or about to start. 29 of them are mainly about Intestinal Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 12 narrower conditions too, such as Colorectal Neoplasms: 10,212 studies, 2,716 open.

Get an email when these change. Save the Intestinal Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
50
Status unknown
20
Recruiting
18
Not yet recruiting
7
Active, not recruiting
7
Terminated
7

Phase

Phase 2
29
Phase 1
19
Phase 3
11
Phase 4
2

Where

United States
36
China
23
United Kingdom
19
Canada
13
Spain
13
France
12

Who runs them

Exact Sciences Corporation (6) · RenJi Hospital (5) · Isofol Medical AB (3) · Royal Marsden NHS Foundation Trust (3) · Revolution Medicines, Inc. (3) · Magentiq Eye LTD (2) · South Tyneside and Sunderland NHS Foundation Trust (2) · Fudan University (2)

What is being tested here

Drugs under test in Intestinal Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Artesunate202
Daraxonrasib202
Irinotecan122
Elironrasib102
Bevacizumab122
Anti-PD-1/Anti-VEGF Bispecific Antibody PF-08634404111
Repotrectinib101
SGM-101101
Ciprofol101
Fluorouracil012

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 1 open · Immune checkpoint inhibitors 1 open

Coming up

5phase 3 studies under way
8studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 8, phase 3 first

Who these studies take

Of the 18 Intestinal Neoplasms studies recruiting now, 13 (72%) set no upper age limit and 2 (11%) stop at 75 or younger. 2 (11%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 18
AgeWomenMen
101 (6%)1 (6%)
1817 (94%)17 (94%)
3017 (94%)17 (94%)
4017 (94%)17 (94%)
5018 (100%)18 (100%)
6517 (94%)17 (94%)
7517 (94%)17 (94%)
8514 (78%)14 (78%)

Across all 110 studies, recruiting or not: 15% stop at 75 or younger and 4% at 65; 7% take children; 1% are for women only and 0% for men only; 15% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Intestinal Neoplasms studies take

Of 17 observational studies under Intestinal Neoplasms, half reached primary completion within 33 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase14 mo11–26 · 13 studies——
Observational33 mo24–78 · 17 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 110. Browse all 110 → or search them.